Skip to main content

MEDI

ETF
—
—

Performance overview

MEDI Price
Price Chart

Forward-looking statistics

Beta
0.25
Risk
18.26%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

—

Fund info

—

Investing methodActively Managed
DiversifiedNo
Expense ratio0.45%
Asset classUnknown

Company info

Sector—
Industry—
Website—
AUM—

Security info

ExchangeNyse American
Type of shareN/A
Earnings per share (EPS)—
Dividend per share$0.54
Revenue per share—
Avg trading volume (30 day)$41K
Avg trading volume (10 day)$62K
Put-call ratioN/A

Macro factor sensitivity

Growth+0.6
Credit+2.9
Liquidity-0.7
Inflation-0.9
Commodities+0.6
Interest Rates-1.1

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend dayDecember 20, 2024

News

ETFs to Buy as Mounjaro Powers Eli Lilly's Q4 Earnings Beat

Eli Lilly and Company (LLY) posted robust fourth-quarter 2023 earnings, beating estimates on both the top and bottom lines driven by strong sales of its diabetes and weight-loss treatments.

Zacks Investment Research (February 7, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free